Literature DB >> 15628914

Immunohistochemical expression of wilms tumor gene protein in different histologic subtypes of ovarian carcinomas.

Marianne Waldstrøm1, Anni Grove.   

Abstract

CONTEXT: Immunohistochemical expression of Wilms tumor gene protein (WT1) has previously been described in primary ovarian carcinomas.
OBJECTIVE: To evaluate differences in WT1 expression among different histologic subtypes of ovarian carcinomas and the correlation to the histologic grade.
DESIGN: Ninety-one primary ovarian carcinomas were reviewed, and 1 representative formalin-fixed and paraffin-embedded tissue block was selected. One slide from each case included in the study was immunostained using the WT1 clone 6F-D2. The immunoreactivity was graded according to the percentage of stained tumor cells. Only nuclear staining was considered a positive reaction. A tumor was regarded as negative if less than 1% of the tumor cells was stained.
RESULTS: All serous carcinomas (28/28) showed WT1 expression, whereas all mucinous (14/14) and all clear cell carcinomas (14/14) were negative. The lone malignant Brenner tumor and 3 (60%) of 5 undifferentiated carcinomas included in the study were also negative. The endometrioid carcinomas showed either no reaction for WT1 or were diffusely positive with more than 50% of the tumor cells stained. All the grade 1 tumors (10/10) were negative, whereas 5 (45%) of the 11 grade 2 tumors and 5 (63%) of the 8 grade 3 tumors showed a positive reaction.
CONCLUSION: The present study demonstrates differences in immunohistochemical expression of WT1 among different histologic subtypes of primary ovarian carcinomas. Regarding the endometrioid subtype, the expression seems to be correlated to the histologic grade.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15628914     DOI: 10.5858/2005-129-85-IEOWTG

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.

Authors:  Carlos Parra-Herran; Jordan Lerner-Ellis; Bin Xu; Sam Khalouei; Dina Bassiouny; Matthew Cesari; Nadia Ismiil; Sharon Nofech-Mozes
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.

Authors:  Diana Lim; Rajmohan Murali; Melissa P Murray; Emanuela Veras; Kay J Park; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2016-03       Impact factor: 6.394

3.  Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinoma.

Authors:  Charlotta Andersson; Yusuke Oji; Nina Ohlson; Sihan Wang; Xingru Li; Ulrika Ottander; Eva Lundin; Haruo Sugiyama; Aihong Li
Journal:  Cancer Med       Date:  2014-04-08       Impact factor: 4.452

4.  Primary peritoneal carcinoma metastasizing to breast: a single case report and literature review from clinic to biology.

Authors:  Ji-Yuan Sun; Wondwossen Gebre; Yi-Min Dong; Xiao Shaun; Rachel Robbins; Alida Podrumar
Journal:  Cancer Biol Med       Date:  2016-09       Impact factor: 4.248

5.  A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies.

Authors:  Siqing Fu; David E Piccioni; Hongtao Liu; Rimas V Lukas; Santosh Kesari; Dawit Aregawi; David S Hong; Kenichiro Yamaguchi; Kate Whicher; Yi Zhang; Yu-Luan Chen; Nagaraju Poola; John Eddy; David Blum
Journal:  Sci Rep       Date:  2021-11-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.